Jefferies Group's XERS Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 293,670 shares of Xeris Biopharma Holdings, Inc. (XERS) worth $2.33 M, representing 0.02% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in XERS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 205,870 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Xeris Biopharma Holdings (XERS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Xeris Biopharma Holdings (XERS) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +205,870 | Add 234.48% | 293,670 | $7.92 |
| Q4 2025 | +87,800 | New Buy | 87,800 | $7.85 |
Jefferies Group's Xeris Biopharma Holdings Investment FAQs
Jefferies Group first purchased Xeris Biopharma Holdings, Inc. (XERS) in Q4 2025, acquiring 87,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Xeris Biopharma Holdings, Inc. (XERS) for 3 quarters since Q4 2025.
Jefferies Group's largest addition to Xeris Biopharma Holdings, Inc. (XERS) was in Q2 2026, adding 293,670 shares worth $2.33 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 293,670 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $2.33 M.
As of the Q2 2026 filing, Xeris Biopharma Holdings, Inc. (XERS) represents approximately 0.02% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Xeris Biopharma Holdings, Inc. (XERS) was 293,670 shares, as reported at the end of Q2 2026.